30
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
Public Timelines
FAQ
Menu
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Open cabinet
Créer
Close
Create a timeline
Public timelines
Library
FAQ
Télécharger
Export
Créer une copie
Premium
Intégrer dans le site Web
DME Studies
Éditer
mise à jour avec succès 7 août 2018
0
0
220
Share
Auteurs
Created by
Thiago Moulin
List of Edits
Attachments
Comments
Les événements
Pegaptanib safe/effective
BOLT study: More evidence on the benefit of bevacizumab
DRCR.net Protocol H: Bevacizumab safe/effective
DRCR.net Protocol I: Ranibizumab better than focal laser ± triamcinolone
RESTORE study: Ranibizumab ± focal laser better than focal laser alone
RISE/RIDE studies: Phase III RCT for Ranibizumab
FDA approves Ranibizumab for DME
DA VINCI study: Aflibercept safe/effective
VIVID/VISTA studies: Phase III RCT for Aflibercept
FDA approves Aflibercept for DME
FDA approves dexamethasone implant for DME
FDA approves 0.19 mg fluocinolone implant for DME
MEAD study: Phase III RCT for dexamethasone implant
FAME study: Phase III RCT for 0.19 fluocinolone implant
About & Feedback
Un accord
Confidentialité
Bibliothèque
2024
©
Time.Graphics
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on
Trustpilot.com
Comments